MFVL - ETF AI Analysis
Top Page
Motley Fool Value Factor ETF (MFVL)
MFVL’s rating reflects a solid mix of high-quality value stocks, led by strong contributors like Salesforce, Bristol-Myers Squibb, Exxon Mobil, and T-Mobile, which bring robust financial performance, positive earnings calls, and strategic growth initiatives to the portfolio. The fund’s score is held back somewhat by weaker names such as CVS Health and HCA Healthcare, where leverage, profitability challenges, and specific corporate issues add risk. A key risk factor is the fund’s exposure to companies with high debt and signs of bearish technical momentum, which could increase volatility despite the overall strength of its core holdings.
MFVL vs. SPDR S&P 500 ETF (SPY)
- AUM
- 7.74M
- Region
- North America
- Expense Ratio
- 0.50%
- Beta
- 0.33
- Issuer
- Motley Fool
- Inception Date
- Dec 08, 2025
- Dividend Yield
- N/A
- Asset Class
- Equity
- Index Tracked
- Motley Fool Value Index - Benchmark TR Gross
MFVL Summary
The Motley Fool Value Factor ETF (MFVL) is a fund that follows the Motley Fool Value Index, focusing on large U.S. companies that its research team believes are trading for less than they’re really worth. It holds a mix of sectors like technology, financials, health care, and energy, with well-known names such as Exxon Mobil and Berkshire Hathaway. Someone might invest in MFVL to seek long-term growth by buying a basket of “value” stocks chosen by experts. A key risk is that these value stocks can stay out of favor for long periods and the share price can rise or fall with the overall stock market.
How much will it cost me?
This ETF has an expense ratio of 0.50%, which means you’ll pay about $5 per year for every $1,000 you invest. That’s higher than the average low-cost index ETF because this fund follows a more specialized, actively designed strategy based on Motley Fool’s proprietary value-focused index.
What would affect this ETF?
This U.S. large-cap value ETF could benefit if the economy grows steadily, consumer spending stays healthy, and sentiment improves toward value stocks, which would support holdings like Chevron, FedEx, Walmart, and Disney across consumer, energy, and industrial sectors. On the other hand, a U.S. slowdown, higher interest rates, or sector-specific challenges in areas like consumer cyclical, health care, or energy could hurt company profits and weigh on the fund’s performance.
MFVL Top 10 Holdings
MFVL leans heavily into U.S. value names, with energy giants Exxon Mobil and Chevron doing much of the heavy lifting as their shares keep rising on strong cash generation and disciplined spending. Berkshire Hathaway B adds a steady, ballast-like presence, helping smooth out bumps elsewhere. On the flip side, T-Mobile is clearly dragging the fund, and Capital One’s mixed results aren’t helping. CVS and Salesforce are more of a mixed bag, with recent volatility. Overall, the fund is a U.S.-centric blend of energy, financials, and health care value plays.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 XOM | Exxon Mobil | 5.29% | $408.94K | $739.77B | 55.18% | 74Outperform |
 CVX | Chevron | 5.16% | $399.52K | $450.93B | 46.98% | 71Outperform |
 BRK.B | Berkshire Hathaway B | 4.98% | $385.09K | $1.16T | 11.25% | 66Neutral |
 DIS | Walt Disney | 4.79% | $370.72K | $190.33B | -1.88% | 75Outperform |
 CVS | CVS Health | 4.75% | $367.44K | $116.55B | 10.53% | 64Neutral |
 CRM | Salesforce | 4.75% | $367.45K | $198.25B | -5.71% | 80Outperform |
 COF | Capital One Financial | 4.46% | $345.41K | $122.37B | -8.97% | 71Outperform |
 TMUS | T Mobile US | 4.10% | $317.22K | $157.50B | -33.46% | 76Outperform |
 BMY | Bristol-Myers Squibb | 4.04% | $312.61K | $125.73B | 41.85% | 78Outperform |
 HCA | HCA Healthcare | 3.29% | $254.50K | $97.42B | -3.83% | 70Neutral |
MFVL Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For MFVL, the sentiment is Positive. The current price of 22.52 is above the 20-day moving average (MA) of 22.00, above the 50-day MA of 22.16, and above the 200-day MA of 20.97, indicating a bullish trend. The MACD of 0.27 indicates Negative momentum. The RSI at 57.58 is Neutral, neither overbought nor oversold. The STOCH value of 61.59 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for MFVL.
MFVL Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| MFVL | $22.52 | $24.00(6.56% Upside) | $7.74M | 0.50% | 71Outperform |
 PRXV | $36.20 | $41.71(15.21% Upside) | $94.88M | 0.36% | 72Outperform |
 MAVF | $138.38 | $166.89(20.60% Upside) | $91.18M | 0.75% | 75Outperform |
 STXV | $39.54 | $44.65(12.93% Upside) | $76.08M | 0.18% | 71Outperform |
 NSIV | $26.17 | $29.71(13.53% Upside) | $73.81M | 0.38% | 72Outperform |
 PZLV | $31.28 | $35.27(12.77% Upside) | $72.12M | 0.60% | 67Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| MFVL | Motley Fool Value Factor ETF | 22.52 | 2.50 | 12.47% | |
| PRXV | Praxis Impact Large Cap Value ETF | 36.20 | 7.27 | 25.13% | |
| MAVF | Matrix Advisors Value ETF | 138.38 | 21.50 | 18.39% | |
| STXV | Strive 1000 Value ETF | 39.53 | 8.08 | 25.70% | |
| NSIV | North Square Disciplined Value ETF | 26.17 | 1.08 | 4.31% | |
| PZLV | Pzena U.S. Large Cap Value ETF | 31.28 | 6.18 | 24.60% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.